TP53 and pancreatic adenocarcinoma: There were 105 P53 nonsynonymous mutations in pancreatic adenocarcinoma samples, 9 of them being R248L/Q/W in the kinase domain (Fig 3), illustrating that these were hotspots for protein activation.